Free shipping on all orders over $ 500

SKI-178

Cat. No. M13356
SKI-178  Structure
Size Price Availability Quantity
5mg USD 82  USD82 In stock
10mg USD 105  USD105 In stock
25mg USD 185  USD185 In stock
50mg USD 298  USD298 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

SKI-178 is a potent sphingosine kinase-1 (SphK1) and SphK2 inhibitor. In acute myeloid leukemia (AML) cell lines, the IC50 range is about 500 nm-1 μM. Ski-178 induces apoptosis of human acute myeloid leukemia cells in a CDK1-dependent manner.

Chemical Information
Molecular Weight 394.42
Formula C21H22N4O4
CAS Number 1259484-97-3
Solubility (25°C) DMSO ≥ 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jeremy A Hengst, et al. Bioorg Med Chem Lett. Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization

[2] Heba Alshaker, et al. Breast Cancer Res Treat. Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors

[3] Jeremy A Hengst, et al. Cancer Transl Med. SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models

[4] Francis R LeBlanc, et al. Cancer Biol Ther. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia

[5] Taryn E Dick, et al. J Pharmacol Exp Ther. The apoptotic mechanism of action of the sphingosine kinase 1 selective inhibitor SKI-178 in human acute myeloid leukemia cell lines

Related SPHK Products
SLM6031434 hydrochloride 

SLM6031434 hydrochloride is a highly selective sphingosine kinase 2 (SphK2) inhibitor with Kis of 0.4 μM, 0.5 μM, >20 μM, 22 μM for mSphK2, rSphK2, mSphK1 and rSphK1, respectively. SLM6031434 hydrochloride decrease Sphingosine 1-phosphate (S1P) levels in U937 monocytic leukemia cells. SLM6031434 hydrochloride has the potential for renal fibrosis research.

N,N-Dimethylsphingosine 

N,N-Dimethylsphingosine is a potent inhbitor of SphK (sphingosine kinase) as an endogenous metabolite of sphingosine produced in various tissues and tumor cell lines.

SKI-V

SKI V is a noncompetitive and potent inhibitor of non-lipid sphingosine kinase with IC50 of 2 μM for GST-hSK. SKI-V also inhibits PI3K with IC50 of 6 μM for hPI3k. SKI-V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) and induces apoptosis with antitumor activity.

WAY-604116

WAY-604116 is a sphingosine kinase inhibitor

WAY-358981

WAY-358981 is a Sphingosine kinase inhibitor

  Catalog
Abmole Inhibitor Catalog




Keywords: SKI-178 supplier, SPHK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.